Rip1 is required for IB kinase activation in response to tumor necrosis factor ␣ (TNF-␣) and has been implicated in the Toll-like receptor 3 (TLR3) response to double-stranded RNA. Cytokine production is impaired when rip1؊/؊ cells are treated with TNF-␣, poly(I-C), or lipopolysaccharide, implicating Rip1 in the Trif-dependent TLR3 and TLR4 pathways. To examine the role of Rip1 in the Trif-dependent TLR4 pathway, we generated rip1؊/؊ MyD88؊/؊ cells. Lipopolysaccharide failed to stimulate NF-B activation in rip1؊/؊MyD88؊/؊ cells, revealing that Rip1 is also required for the Trif-dependent TLR4-induced NF-B pathway. In addition to activating NF-B, TLR3/4 pathways also stimulate interferon regulatory factor 3 activation. However, we find that Rip1 expression stimulates NF-B but not interferon regulatory factor 3 activity. In the TNF-␣ pathway, Rip1 interacts with the E3 ubiquitin ligase Traf2 and is modified by polyubiquitin chains. Upon TLR3 activation, Rip1 is also modified by polyubiquitin chains and is recruited to TLR3 along with Traf6 and the ubiquitinactivated kinase Tak1. These studies suggest that Rip1 uses a similar, ubiquitin-dependent mechanism to activate IB kinase- in response to TNF-␣ and TLR3 ligands.The death domain kinase Rip1 (receptor-interacting protein 1) mediates TNF-␣ 2 -induced NF-B and p38 mitogen-activated protein kinase activation (1-4). Although Rip1 is required for IKK activation (5), its kinase activity is dispensable (3, 6), suggesting that Rip1 may mediate IKK activation by recruiting other MAP kinases such as Mekk3 or by employing other mechanisms to achieve IKK activation. Upon recruitment to the TNF receptor (TNFR1), Rip1 is initially modified by K63-linked polyubiquitin chains. These K63-linked polyubiquitin chains are recognized by the ubiquitin receptor Tab2 (7), resulting in the recruitment of the ubiquitin-activated Tak1 (TGF--activating kinase 1) enzyme to the TNFR1.Recently, Rip1 has also been implicated in the Toll-like receptor 3 (TLR3)-mediated NF-B response to dsRNA (8). Rip1 interacts with the TLR3-and TLR4-specific adapter Trif (Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-). Trif is a TIR domain-containing adapter protein that is essential for all signaling by TLR3 and some signaling by TLR4. Rip1 binds the C terminus of the Trif protein via a Rip homotypic interaction motif (8). Trif also binds Traf6 (tumor necrosis factor receptor-associated factor-6) and TBK-1 via its N terminus, and these interactions result in interferon regulatory factor 3 (IRF-3) activation. The TLR4 ligand LPS induces NF-B activation by engaging the MyD88-dependent and Trif-dependent pathways. Thus, we reasoned that Rip1 may also participate in late phase NF-B activation induced by TLR4 Trif-dependent pathway.We find NF-B responses and cytokine production ablated when rip1Ϫ/Ϫ murine embryonic fibroblasts (MEF) or splenocytes are stimulated with dsRNA or TNF-␣. Although the NF-B responses to TLR4 appear unaffected due to activation of the MyD88-dependent pathway, LPS-...